The Company committed to organizational restructurings during the fourth quarter of 2024, designed to decrease its costs and create a more streamlined organization to support its business. These liabilities are included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets.

The Company’s restructuring costs, primarily for cash severance and other severance costs, are allocated to the following operating expense categories as follows (in thousands):


	Research and Development		Selling, general and administrative		Total
Balance as of December 31, 2024	$	513	$	166	$	679
Restructuring charges incurred(1)	312		—		312
Cash payments and other adjustments(1)	(825)		(166)		(991)
Balance as of December 31, 2025	$	—	$	—	$	—
Current liabilities					$	—
Long-term liabilities					—
Total liabilities as of December 31, 2025					$	—

(1) Restructuring charges incurred and Cash payments and other adjustments include non-cash charges related to stock-based compensation expense and charges for cash severance and other severance costs, including health care coverage for a specified period of time after separation.

The Company’s restructuring activities were complete as of December 31, 2024 and, as of December 31, 2025, the Company does not expect to incur additional charges associated with these activities.